Innate Pharma S.A. - Neraca (Quarterly)

Innate Pharma S.A.
GB ˙ BATS-CHIXE ˙ FR0010331421
Talaan ng Balanse (Quarterly)

Neraca Innate Pharma S.A. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
Cash 137 137 104 104 104 103 103 84 84 71 71 71 71 70 70 66 66
Change (%) 0.00 -23.99 0.00 -0.22 -0.78 0.00 -18.19 0.00 -15.21 0.00 -1.13 0.00 -0.87 0.00 -5.14 0.00
Assets Current 173 173 130 130 138 172 172 140 140 144 144 148 148 112 112 86 86
Change (%) 0.00 -25.23 0.00 6.61 24.26 0.00 -18.61 0.00 3.31 0.00 2.46 0.00 -24.61 0.00 -23.17 0.00
Assets 307 307 266 266 267 280 280 208 199 199 199 175 175 151 151 111 111
Change (%) 0.00 -13.40 0.00 0.48 4.84 0.00 -25.88 -4.12 -0.12 0.00 -11.99 0.00 -13.52 0.00 -26.69 0.00
Liabilities 151 151 133 133 160 164 164 154 145 141 141 123 123 123 123 102 102
Change (%) 0.00 -12.41 0.00 20.65 2.52 0.00 -6.33 -5.57 -2.73 0.00 -12.68 0.00 -0.47 0.00 -16.69 0.00
Equity 156 156 134 134 107 116 116 54 54 58 58 52 52 29 29 9 9
Change (%) 0.00 -14.37 0.00 -19.56 8.28 0.00 -53.45 0.00 6.85 0.00 -10.30 0.00 -44.52 0.00 -69.32 0.00
Liabilities And Stock Equity 307 307 266 266 267 280 280 208 199 199 199 175 175 151 151 111 111
Change (%) 0.00 -13.40 0.00 0.48 4.84 0.00 -25.88 -4.12 -0.12 0.00 -11.99 0.00 -13.52 0.00 -26.69 0.00

Source: Capital IQ

Other Listings
IT:4IPH
FR:IPH € 1.77
GB:0EVI € 1.79
US:IPHYF
DE:IDD € 1.84
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista